Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia

Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia

Background. Withdrawal syndrome (WS) a musculoskeletal pain after discontinuation of tyrosine kinase inhibitors (TKI) in patients with chronic myeloid leukemia (CML) has been described in the treatment-free remission (TFR) studies. The pathophysiological mechanisms and predisposing factors of WS h...

Full description

Bibliographic Details
Main Authors: Ekaterina Yu. Chelysheva, Anna N. Petrova, Oleg A. Shukhov, Anastasiia V. Bykova, Irina S. Nemchenko, Margarita A. Gurianova, Nikolay N. Tsyba, Anna G. Turkina
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2022-08-01
Series:Терапевтический архив
Subjects:
сhronic myeloid leukemia
deep molecular response
treatment free remission
withdrawal syndrome
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/109734/83975

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/109734/83975

Similar Items